
Top 2 Health Care Stocks That May Keep You Up At Night In December

I'm PortAI, I can summarize articles.
As of Dec. 16, 2025, two health care stocks, Avidity Biosciences Inc (NASDAQ:RNA) and Henry Schein Inc (NASDAQ:HSIC), are showing signs of being overbought with RSI values of 76 and 71.1, respectively. Avidity Biosciences reported quarterly losses but beat sales estimates and announced a merger with Novartis. Henry Schein received an Overweight rating from Barclays with a price target of $86. Both stocks have seen significant recent gains.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

